Jacinda Abdul-mutakabbir

Title(s)Assistant Professor Of Clinical, School of Pharmacy and Pharmaceutical Science
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Striving for Equity in Academia: Embracing the Power of No in Decision-Making. FEMS Microbiol Lett. 2023 Oct 20. Swartz TH, Abdul-Mutakabbir JC. PMID: 37863835.
      View in: PubMed   Mentions:    Fields:    
    2. The Implications of Data Aggregation on Propagating Racial and Ethnic Disparities within the Healthcare Landscape: Actionable Recommendations and Considerations for Pharmacists. J Am Pharm Assoc (2003). 2023 Oct 19. Camara E, Safri A, Ko CL, Abdul-Mutakabbir JC, Bandali A, Brown BR, PharmGradWishlist Leadership Team. PMID: 37865310.
      View in: PubMed   Mentions:    Fields:    
    3. Targeting Dalbavancin Inoculum Effect: Adjunctive Single Dose of Daptomycin. Infect Dis Ther. 2023 Oct 05. Kebriaei R, Abdul-Mutakabbir JC, Stamper KC, Lev KL, Rybak MJ. PMID: 37798469.
      View in: PubMed   Mentions:
    4. Demographic representation among speakers at the Society for Healthcare Epidemiology of America (SHEA) spring conferences. Infect Control Hosp Epidemiol. 2023 Oct 02; 1-7. Wiley Z, Kalu IC, Lyden E, Cichon CJ, Abdul-Mutakabbir JC, Herskovitz J, Marcelin JR. PMID: 37782036.
      View in: PubMed   Mentions:    Fields:    
    5. Identifying the potential impact of a multidisciplinary outpatient antimicrobial therapy program in an area of high social vulnerability. Ther Adv Infect Dis. 2023 Jan-Dec; 10:20499361231194257. Tan KK, Hino G, Zhou AY, Al-Fayiz H, Rodriguez S, Abdul-Mutakabbir JC. PMID: 37636217; PMCID: PMC10460041.
      View in: PubMed   Mentions:
    6. International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary. Pharmacotherapy. 2023 08; 43(8):736-739. Hong LT, Downes KJ, FakhriRavari A, Abdul-Mutakabbir JC, Kuti JL, Jorgensen S, Young DC, Alshaer MH, Bassetti M, Bonomo RA, Gilchrist M, Jang SM, Lodise T, Roberts JA, Tängdén T, Zuppa A, Scheetz MH. PMID: 37615244.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2023 08; 43(8):740-777. Hong LT, Downes KJ, FakhriRavari A, Abdul-Mutakabbir JC, Kuti JL, Jorgensen S, Young DC, Alshaer MH, Bassetti M, Bonomo RA, Gilchrist M, Jang SM, Lodise T, Roberts JA, Tängdén T, Zuppa A, Scheetz MH. PMID: 37615245.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Utilization of a "Diversity Index" to Assess Racial Diversity of US School of Pharmacy Graduates. Am J Pharm Educ. 2023 Jul 04; 100568. Rao KV, Mitrzyk BM, Tillman F, Liu I, Abdul-Mutakabbir JC, Harvin A, Bogucki C, Salsberg E. PMID: 37414218.
      View in: PubMed   Mentions:    Fields:    
    9. Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model. Antimicrob Agents Chemother. 2023 Jun 15; 67(6):e0131722. Morrisette T, Stamper KC, Lev KL, Kebriaei R, Holger DJ, Abdul-Mutakabbir JC, Kunz Coyne AJ, Rybak MJ. PMID: 37222591; PMCID: PMC10269082.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    10. Academic Activism: An Avenue to Action. Am J Pharm Educ. 2023 06; 87(6):100080. Astle KN, Arya V, Blackburn H, Gahbauer A, Hirsch EB, Fravel M, Ko CL, Saunders IM, Abdul-Mutakabbir JC, Brown JE, Childs-Kean LM. PMID: 37316141.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Examining the impact of racial disparities on Clostridioides difficile infection outcomes at a Southern California academic teaching hospital. Infect Control Hosp Epidemiol. 2023 May 04; 1-5. Lee JM, Zhou AY, Ortiz-Gratacos NM, Al Isso A, Tan KK, Abdul-Mutakabbir JC. PMID: 37138348.
      View in: PubMed   Mentions:    Fields:    
    12. Racial disparities among candidemic patients at a Southern California teaching hospital. Infect Control Hosp Epidemiol. 2023 Apr 24; 1-4. Grant VC, Zhou AY, Tan KK, Abdul-Mutakabbir JC. PMID: 37088549.
      View in: PubMed   Mentions:    Fields:    
    13. Slowed progression: The utility of Test to Treat initiatives in improving the neglected inequities of COVID-19 among racially/ethnically minoritized groups. J Am Pharm Assoc (2003). 2023 Jan-Feb; 63(1):424-429. Abdul-Mutakabbir JC, Tillman F, Marcelin JR, Saunders IM, Arya V. PMID: 36470731; PMCID: PMC9625842.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    14. Original Research: COVID-19 Vaccine Hesitancy Among Southern California Nurses. Am J Nurs. 2022 11 01; 122(11):22-31. Roberts LR, Dubov A, Distelberg B, Peteet B, Abdul-Mutakabbir JC, Montgomery S, Patel P, Chrissian AA. PMID: 36201394.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    15. Rapid Implementation of a Community-Academic Partnership Model to Promote COVID-19 Vaccine Equity within Racially and Ethnically Minoritized Communities. Vaccines (Basel). 2022 Aug 20; 10(8). Abdul-Mutakabbir JC, Granillo C, Peteet B, Dubov A, Montgomery SB, Hutchinson J, Casey S, Simmons K, Fajardo A, Belliard JC. PMID: 36016251; PMCID: PMC9415044.
      View in: PubMed   Mentions: 3  
    16. Racial/Ethnic Variances in COVID-19 Inoculation among Southern California Healthcare Workers. Vaccines (Basel). 2022 Aug 17; 10(8). Dubov A, Distelberg BJ, Abdul-Mutakabbir JC, Peteet B, Roberts L, Montgomery SB, Rockwood N, Patel P, Shoptaw S, Chrissian AA. PMID: 36016219; PMCID: PMC9414471.
      View in: PubMed   Mentions: 1  
    17. Exploring the intersection of racism, antimicrobial resistance, and vaccine equity. Antimicrob Steward Healthc Epidemiol. 2022; 2(1):e134. Abdul-Mutakabbir JC, Simiyu B. PMID: 36483434; PMCID: PMC9726476.
      View in: PubMed   Mentions:
    18. Faith, Fear, and Facts: A COVID-19 Vaccination Hesitancy Intervention for Black Church Congregations. Vaccines (Basel). 2022 Jun 28; 10(7). Peteet B, Watts V, Tucker E, Brown P, Hanna M, Saddlemire A, Rizk M, Belliard JC, Abdul-Mutakabbir JC, Casey S, Simmons K. PMID: 35891203; PMCID: PMC9320174.
      View in: PubMed   Mentions: 7  
    19. Leveraging Black pharmacists to promote equity in COVID-19 vaccine uptake within Black communities: A framework for researchers and clinicians. J Am Coll Clin Pharm. 2022 Aug; 5(8):887-893. Abdul-Mutakabbir JC, Simiyu B, Walker RE, Christian RL, Dayo Y, Maxam M. PMID: 35942357; PMCID: PMC9350100.
      View in: PubMed   Mentions: 4  
    20. A call to action: A need for initiatives that increase equitable access to COVID-19 therapeutics. Lancet Reg Health Am. 2022 Jul; 11:100263. Abdul-Mutakabbir JC, Hirsch EB, Ko C, Brown BR, Bandali A, Mordino J, Yoke LH, Bell T, Swartz TH, Syed U, Hlatshwayo M, Saunders IM. PMID: 35600636; PMCID: PMC9114692.
      View in: PubMed   Mentions: 3  
    21. Social Media: Flattening Hierarchies for Women and Black, Indigenous, People Of Color (BIPOC) to Enter the Room Where It Happens. Clin Infect Dis. 2022 05 15; 74(Suppl_3):S222-S228. Titanji BK, Abdul-Mutakabbir JC, Christophers B, Flores L, Marcelin JR, Swartz TH. PMID: 35568478; PMCID: PMC9107375.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Clinical Characteristics Associated with Bacterial Bloodstream Coinfection in COVID-19. Infect Dis Ther. 2022 Jun; 11(3):1281-1296. Rebold N, Alosaimy S, Morrisette T, Holger D, Lagnf AM, Ansari I, Belza AC, Cheaney L, Hussain H, Herbin SR, Abdul-Mutakabbir J, Carron C, Sandhu A, Chopra T, Rybak MJ. PMID: 35538335; PMCID: PMC9090596.
      View in: PubMed   Mentions:
    23. Acknowledging the intersection of gender inequity and racism: Identifying a path forward in pharmacy. Am J Health Syst Pharm. 2022 04 01; 79(8):696-700. Abdul-Mutakabbir JC, Arya V, Butler L. PMID: 34864836.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Brighter horizons: The necessity of concentrated sponsorship targeted toward minoritized student pharmacists. J Am Pharm Assoc (2003). 2022 May-Jun; 62(3):701-705. Ko CL, Abdul-Mutakabbir JC, Astle KN, Bandali A, Brown JE, Childs-Kean LM, Hirsch EB, Mordino J, Saunders IM, Brown BR. PMID: 35367143.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Characterizing Safety and Clinical Outcomes Associated with High-Dose Micafungin Utilization in Patients with Proven Invasive Candidiasis. Trop Med Infect Dis. 2022 Feb 03; 7(2). Grant VC, Nguyen K, Rodriguez S, Zhou AY, Abdul-Mutakabbir JC, Tan KK. PMID: 35202218; PMCID: PMC8878997.
      View in: PubMed   Mentions: 1  
    26. Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy. Drugs Context. 2022; 11. FakhriRavari A, Simiyu B, Morrisette T, Dayo Y, Abdul-Mutakabbir JC. PMID: 35145558; PMCID: PMC8798368.
      View in: PubMed   Mentions: 1  
    27. Predictors of COVID-19 Vaccine Acceptance and Hesitancy among Healthcare Workers in Southern California: Not Just "Anti" vs. "Pro" Vaccine. Vaccines (Basel). 2021 Dec 02; 9(12). Dubov A, Distelberg BJ, Abdul-Mutakabbir JC, Beeson WL, Loo LK, Montgomery SB, Oyoyo UE, Patel P, Peteet B, Shoptaw S, Tavakoli S, Chrissian AA. PMID: 34960171; PMCID: PMC8706436.
      View in: PubMed   Mentions: 13  
    28. Gender Inequity and Sexual Harassment in the Pharmacy Profession: Evidence and Call to Action Executive Summary. J Am Coll Clin Pharm. 2021 Nov; 4(11):1375-1378. Bissell BD, Johnston JP, Smith RR, Newsome AS, Thompson Bastin ML, Abdul-Mutakabbir J, Barlow A, Barlow B, Berger K, Crow JR, Dixit D, Jacobi J, Karaoui LR, Kiser TH, Kolesar J, Koontz SE, Mattingly TJ, Mitchell C, Nilges A, Rech MA, Heavner MS. PMID: 35187415; PMCID: PMC8849554.
      View in: PubMed   Mentions:
    29. Gender inequity and sexual harassment in the pharmacy profession: Evidence and call to action. Am J Health Syst Pharm. 2021 11 09; 78(22):2059-2076. Bissell BD, Johnston JP, Smith RR, Newsome AS, Thompson Bastin ML, Abdul-Mutakabbir J, Barlow A, Barlow B, Berger K, Crow JR, Dixit D, Jacobi J, Karaoui LR, Kiser TH, Kolesar J, Koontz SE, Mattingly TJ, Mitchell C, Nilges A, Rech MA, Heavner MS. PMID: 34232286; PMCID: PMC8344711.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    30. Contemporary Perspective on the Treatment of Acinetobacter baumannii Infections: Insights from the Society of Infectious Diseases Pharmacists. Infect Dis Ther. 2021 Dec; 10(4):2177-2202. Abdul-Mutakabbir JC, Griffith NC, Shields RK, Tverdek FP, Escobar ZK. PMID: 34648177; PMCID: PMC8514811.
      View in: PubMed   Mentions: 15  
    31. In Vitro Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2021 08 17; 65(9):e0264620. Abdul-Mutakabbir JC, Nguyen L, Maassen PT, Stamper KC, Kebriaei R, Kaye KS, Castanheira M, Rybak MJ. PMID: 34125590; PMCID: PMC8370208.
      View in: PubMed   Mentions: 17     Fields:    Translation:Cells
    32. Exebacase in Addition to Daptomycin against MRSA. Antimicrob Agents Chemother. 2021 10 18; 65(11):e0012821. Kebriaei R, Stamper KC, Lev KL, Morrisette T, Abdul-Mutakabbir JC, Schuch R, Lehoux D, Rybak MJ. PMID: 34398668; PMCID: PMC8522749.
      View in: PubMed   Mentions: 6     Fields:    Translation:Cells
    33. Addressing and Inspiring Vaccine Confidence in Black, Indigenous, and People of Color During the Coronavirus Disease 2019 Pandemic. Open Forum Infect Dis. 2021 Sep; 8(9):ofab417. Marcelin JR, Swartz TH, Bernice F, Berthaud V, Christian R, da Costa C, Fadul N, Floris-Moore M, Hlatshwayo M, Johansson P, Kullar R, Manning K, McGee EU, Medlin C, Piggott DA, Syed U, Snowden J, Tan T, Abdul-Mutakabbir JC. PMID: 34580644; PMCID: PMC8385873.
      View in: PubMed   Mentions: 16  
    34. Diversity in probiotics and diversity in clinical trials: Opportunities for improvement. Infect Control Hosp Epidemiol. 2022 10; 43(10):1508-1509. Marcelin JR, Fadul N, Cawcutt KA, Abdul-Mutakabbir JC. PMID: 34325752.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii. Antibiotics (Basel). 2021 Jul 20; 10(7). Abdul-Mutakabbir JC, Yim J, Nguyen L, Maassen PT, Stamper K, Shiekh Z, Kebriaei R, Shields RK, Castanheira M, Kaye KS, Rybak MJ. PMID: 34356801; PMCID: PMC8300792.
      View in: PubMed   Mentions: 5  
    36. Ten recommendations to increase Black representation within pharmacy organization leadership. Am J Health Syst Pharm. 2021 05 06; 78(10):896-902. Allen JM, Abdul-Mutakabbir JC, Campbell HE, Butler LM. PMID: 33954422.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    37. Community-academic partnerships to reduce COVID-19 vaccine hesitancy in minoritized communities. EClinicalMedicine. 2021 Apr; 34:100834. Peteet B, Belliard JC, Abdul-Mutakabbir J, Casey S, Simmons K. PMID: 33880441; PMCID: PMC8049608.
      View in: PubMed   Mentions: 13  
    38. A three-tiered approach to address barriers to COVID-19 vaccine delivery in the Black community. Lancet Glob Health. 2021 06; 9(6):e749-e750. Abdul-Mutakabbir JC, Casey S, Jews V, King A, Simmons K, Hogue MD, Belliard JC, Peverini R, Veltman J. PMID: 33713634; PMCID: PMC7946412.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansPHPublic Health
    39. The (Contrasted) Ethics of Covid-19 and HIV: Will the Favor be Returned? J Healthc Sci Humanit. 2021; 11(1):107-121. Campbell HE, Abdul-Mutakabbir JC, Hodge DA. PMID: 36818213; PMCID: PMC9930501.
      View in: PubMed   Mentions:
    40. Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug-Resistant Gram-Negative Pathogens. Pharmacotherapy. 2020 12; 40(12):1228-1247. Abdul-Mutakabbir JC, Alosaimy S, Morrisette T, Kebriaei R, Rybak MJ. PMID: 33068441.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    41. The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA-Salvaging the Gold Standards with Combination Therapy. Antibiotics (Basel). 2020 Oct 30; 9(11). Morrisette T, Alosaimy S, Abdul-Mutakabbir JC, Kebriaei R, Rybak MJ. PMID: 33143290; PMCID: PMC7692208.
      View in: PubMed   Mentions: 11  
    42. Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model. Antibiotics (Basel). 2020 Oct 14; 9(10). Abdul-Mutakabbir JC, Kebriaei R, Stamper KC, Sheikh Z, Maassen PT, Lev KL, Rybak MJ. PMID: 33066415; PMCID: PMC7602181.
      View in: PubMed   Mentions: 7  
    43. Bacteriophage-Antibiotic Combinations for Enterococcus faecium with Varying Bacteriophage and Daptomycin Susceptibilities. Antimicrob Agents Chemother. 2020 08 20; 64(9). Morrisette T, Lev KL, Kebriaei R, Abdul-Mutakabbir JC, Stamper KC, Morales S, Lehman SM, Canfield GS, Duerkop BA, Arias CA, Rybak MJ. PMID: 32571816; PMCID: PMC7449186.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    44. Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study. Clin Infect Dis. 2020 06 24; 71(1):1-10. Jorgensen SCJ, Zasowski EJ, Trinh TD, Lagnf AM, Bhatia S, Sabagha N, Abdul-Mutakabbir JC, Alosaimy S, Mynatt RP, Davis SL, Rybak MJ. PMID: 31404468.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    45. Bacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureus. Antimicrob Agents Chemother. 2020 06 23; 64(7). Kebriaei R, Lev K, Morrisette T, Stamper KC, Abdul-Mutakabbir JC, Lehman SM, Morales S, Rybak MJ. PMID: 32393490; PMCID: PMC7318012.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    46. Evaluation of Eravacycline: A Novel Fluorocycline. Pharmacotherapy. 2020 03; 40(3):221-238. Alosaimy S, Abdul-Mutakabbir JC, Kebriaei R, Jorgensen SCJ, Rybak MJ. PMID: 31944332.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    47. Teaching an Old Class New Tricks: A Novel Semi-Synthetic Aminoglycoside, Plazomicin. Infect Dis Ther. 2019 Jun; 8(2):155-170. Abdul-Mutakabbir JC, Kebriaei R, Jorgensen SCJ, Rybak MJ. PMID: 30850956; PMCID: PMC6522576.
      View in: PubMed   Mentions: 4  
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Jacinda's Networks
    Concepts (64)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (3)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-2-gbbe5f151 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California